⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SABS News
SAB Biotherapeutics, Inc. Common Stock
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
globenewswire.com
SABS
Form 8-K
sec.gov
SABS
SABSW
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
globenewswire.com
SABS
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
globenewswire.com
SABS
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
globenewswire.com
SABS
SAB BIO to Participate in Upcoming Investor Conferences
globenewswire.com
SABS
SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
globenewswire.com
SABS
SABSW
SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
globenewswire.com
SABS
SABSW
SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET
globenewswire.com
SABS
Form 8-K
sec.gov
SABS
SABSW